TORONTO — Licensed marijuana producer Bedrocan is slashing the price of all six of its medical cannabis strains to $5 a gram, citing a desire to make medicine more affordable for patients.
The company's products previously cost $7.50 a gram.
Bedrocan Canada Inc. is a subsidiary of Canopy Growth Corp. (TSXV:CGC), a combined company formed when Bedrocan merged with Tweed Marijuana Inc.
Bedrocan president Marc Wayne says the company will still be able to turn a profit, even after price cuts that amount to roughly 33 per cent.
"We're very good at producing cannabis at a low cost," said Wayne.
"After spending the last six months perfecting production techniques in Canada from our Dutch partners in Holland, we now have the ability to reduce our cost."
